A Phase II, Multicenter, Randomized, Open-label Study to Investigate the Safety and Efficacy of Pegfilgrastim (Neulasta) in Patients With Alcoholic Hepatitis

Trial Profile

A Phase II, Multicenter, Randomized, Open-label Study to Investigate the Safety and Efficacy of Pegfilgrastim (Neulasta) in Patients With Alcoholic Hepatitis

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 24 May 2016

At a glance

  • Drugs Pegfilgrastim (Primary) ; Pentoxifylline (Primary) ; Prednisolone (Primary)
  • Indications Alcoholic hepatitis
  • Focus Adverse reactions
  • Most Recent Events

    • 24 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top